发明名称 |
CD45RB BONDING COMPOUND FOR PREVENTING GRAFT REJECTION |
摘要 |
<p><P>PROBLEM TO BE SOLVED: To provide a new compound and a new medicinal composition each useful for controlling immune response. <P>SOLUTION: The method is for treating or preventing graft rejection for cell, organization or organ of a receptor, wherein the method comprises administering a pharmacologically effective amount of at least one compound bondable to CD45RB leukocyte antigen for inhibiting T-cell internuncial immune response of the receptor against the graft. <P>COPYRIGHT: (C)2004,JPO</p> |
申请公布号 |
JP2004067700(A) |
申请公布日期 |
2004.03.04 |
申请号 |
JP20030332390 |
申请日期 |
2003.09.24 |
申请人 |
RESEARCH CORP TECHNOLOGIES INC |
发明人 |
LAZAROVITS ANDREW I;POPPEMA SIBRANDES |
分类号 |
C12N15/02;A61K31/164;A61K31/421;A61K31/436;A61K31/573;A61K38/00;A61K38/45;A61K39/395;A61K45/00;A61K47/00;A61P19/02;A61P25/00;A61P29/00;A61P37/06;C07K16/28;C07K16/40;C12P21/08;C12R1/91;(IPC1-7):A61K45/00 |
主分类号 |
C12N15/02 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|